Loading...

Anti-CD20 monoclonal antibodies: reviewing a revolution

Since the inception of rituximab in the 1990s, anti-CD20 monoclonal antibodies have revolutionised the treatment of B cell hematological malignancies and have become a cornerstone of modern gold-standard practice. Additionally, the potent efficacy of these agents in depleting the B cell compartment...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hum Vaccin Immunother
Main Authors: Casan, J. M. L., Wong, J., Northcott, M. J., Opat, S.
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6343614/
https://ncbi.nlm.nih.gov/pubmed/30096012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1508624
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!